A multicenter study to evaluate the ability of NGS analysis of plasma samples to detect driver oncogenes in lung cancer
Not Applicable
- Conditions
- lung cancer
- Registration Number
- JPRN-UMIN000048870
- Lead Sponsor
- Cancer Institute Hospital of Japan Foundation for Cancer Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 302
Inclusion Criteria
Not provided
Exclusion Criteria
non
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The concordance rate of gene subtypes diagnosis between based on pathology diagnosis and on plasma analysis
- Secondary Outcome Measures
Name Time Method 1. Efficacy of molecular targeted therapy (response rate, progression-free survival) 2. Detection rate of driver genes by plasma analysis 3. Rate of confirmed gene subtypes by plasma analysis in cases in which driver gene analysis was not possible